Reported about 1 year ago
The Asia Biotech Conference in 2024, chaired by Li Zhongxi, featured about 900 exhibitors and over 2,200 booths, marking a record scale. The event showcased the CDMO trend sparked by Roivant Sciences' acquisition of a US pharmaceutical company, and advancements in Next-Generation Sequencing (NGS) and regenerative medicine. Discussions focused on global biotech opportunities with forums on innovation, investment, and regional cooperation. Notable companies like Yuyan and Genon-Bio are raising Taiwan's international visibility. Various sectors, including CDMO, regenerative medicine, precision medicine, and new drug and medical device manufacturers, participated in the event exhibiting their contributions to the industry.
Source: YAHOO